Profile data is unavailable for this security.
About the company
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.
- Revenue in CAD (TTM)0.00
- Net income in CAD-40.73m
- Incorporated2001
- Employees--
- LocationSernova Corp700 Collip Circle, Ste 114LONDON N6G 4X8CanadaCAN
- Phone+1 (519) 858-5126
- Fax+1 (519) 858-5126
- Websitehttps://www.sernova.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Theratechnologies Inc | 106.94m | -24.64m | 78.63m | 89.00 | -- | -- | -- | 0.7353 | -0.8483 | -0.8483 | 3.28 | -0.7326 | 1.03 | 1.89 | 7.81 | -- | -23.78 | -26.32 | -128.23 | -55.43 | 74.10 | 65.90 | -23.04 | -38.26 | 1.03 | -0.919 | 1.71 | -- | 2.13 | 12.58 | 49.28 | -- | -37.83 | -- |
Arch Biopartners Inc | 1.50m | -2.14m | 107.27m | -- | -- | -- | -- | 71.51 | -0.0341 | -0.0341 | 0.024 | -0.1025 | 0.5472 | -- | 0.6897 | -- | -78.01 | -214.82 | -- | -- | -- | -- | -142.55 | -180.45 | -- | -4.06 | -- | -- | 105.63 | -- | -136.30 | -- | -- | -- |
Biosyent Inc | 32.84m | 7.05m | 109.65m | 0.00 | 15.88 | 3.13 | 14.59 | 3.34 | 0.5856 | 0.5856 | 2.72 | 2.97 | 0.8341 | 1.23 | 10.80 | -- | 17.92 | 14.77 | 20.00 | 16.92 | 80.41 | 79.74 | 21.48 | 19.99 | 6.37 | -- | 0.0329 | 9.26 | 13.12 | 7.97 | 18.35 | 2.52 | -2.67 | -- |
Oncolytics Biotech Inc | 0.00 | -28.21m | 111.62m | 29.00 | -- | 4.86 | -- | -- | -0.4027 | -0.4027 | 0.00 | 0.3046 | 0.00 | -- | -- | -- | -80.51 | -81.99 | -88.84 | -97.25 | -- | -- | -- | -- | -- | -- | 0.0468 | -- | -- | -- | -11.75 | -- | -40.52 | -- |
Sernova Corp | 0.00 | -40.73m | 116.81m | -- | -- | 30.46 | -- | -- | -0.1343 | -0.1343 | 0.00 | 0.0126 | 0.00 | -- | -- | -- | -124.29 | -74.84 | -180.95 | -85.03 | -- | -- | -- | -- | -- | -- | 0.142 | -- | -- | -- | -59.69 | -- | -2.91 | -- |
NervGen Pharma Corp | 0.00 | -20.02m | 125.17m | 10.00 | -- | 6.65 | -- | -- | -0.3363 | -0.3363 | 0.00 | 0.2692 | 0.00 | -- | -- | -- | -78.68 | -121.15 | -138.24 | -180.20 | -- | -- | -- | -- | -- | -9.07 | 0.0092 | -- | -- | -- | -8.01 | -- | 2.20 | -- |
Eupraxia Pharmaceuticals Inc | 0.00 | -41.89m | 130.02m | 29.00 | -- | 4.86 | -- | -- | -1.66 | -1.66 | 0.00 | 0.7512 | 0.00 | -- | -- | 0.00 | -122.29 | -127.84 | -185.74 | -935.99 | -- | -- | -- | -- | -- | -85.63 | 0.3455 | -- | -- | -- | -52.63 | -- | -7.69 | -- |
Spectral Medical Inc | 1.74m | -17.93m | 145.36m | 29.00 | -- | -- | -- | 83.73 | -0.0643 | -0.0647 | 0.0062 | -0.0721 | 0.2507 | 3.23 | 2.19 | 59,862.07 | -258.89 | -109.65 | -18,581.35 | -175.35 | 37.85 | 63.74 | -1,032.89 | -445.72 | 0.3287 | -2.56 | -- | -- | -4.14 | -16.08 | -104.12 | -- | 31.53 | -- |
Zentek Ltd | 33.61k | -11.98m | 151.23m | 27.00 | -- | 6.73 | -- | 4,499.54 | -0.1197 | -0.1197 | 0.0003 | 0.2228 | 0.0013 | 0.0796 | 0.0876 | 1,244.82 | -44.53 | -41.94 | -48.53 | -44.46 | -573.70 | -- | -35,636.60 | -12,771.31 | 4.27 | -- | 0.0538 | -- | -79.01 | -- | 54.52 | -- | 39.27 | -- |